glucose, (beta-d)-isomer has been researched along with loperamide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Déchelotte, P | 1 |
| Asari, T; Fujimori, Y; Fushimi, N; Inoue, T; Isaji, M; Kobayashi, M; Kurooka, T; Nishibe, H; Onozato, T; Takeda, H; Takemura, M | 1 |
2 other study(ies) available for glucose, (beta-d)-isomer and loperamide
| Article | Year |
|---|---|
[Type 1 Gaucher's disease in the adult. Nutritional management during initiation of treatment with miglustat].
Topics: Adult; Antidiarrheals; Combined Modality Therapy; Diarrhea; Dietary Carbohydrates; Disaccharides; Dose-Response Relationship, Drug; Fructose; Gastrointestinal Transit; Gaucher Disease; Glucosides; Glucosylceramidase; Humans; Loperamide; Malabsorption Syndromes; Monosaccharides; Probiotics; Recombinant Proteins; Risk Factors | 2004 |
Mizagliflozin, a novel selective SGLT1 inhibitor, exhibits potential in the amelioration of chronic constipation.
Topics: Amides; Animals; Chronic Disease; Clinical Trials, Phase I as Topic; Constipation; Dietary Fiber; Dogs; Dose-Response Relationship, Drug; Glucosides; Humans; Loperamide; Male; Pyrazoles; Rats; Sodium-Glucose Transporter 1 | 2017 |